Advances in omics for informed pharmaceutical research and development in the era of systems medicine

Expert Opin Drug Discov. 2018 Jan;13(1):1-4. doi: 10.1080/17460441.2018.1394839. Epub 2017 Oct 27.

Authors

Jane P F Bai¹, Ioannis N Melas², Junguk Hur³, Ellen Guo⁴

Affiliations

¹ a Office of Clinical Pharmacology , Center for Drug Evaluation and Research, U.S. Food and Drug Administration , Silver Spring , Maryland , USA.
² b Translational Bioinformatics , UCB Celltech , Slough , UK.
³ c Department of Biomedical Sciences , University of North Dakota, School of Medicine & Health Sciences , Grand Forks , North Dakota , USA.
⁴ d College of Pharmacy , University of Illinois at Chicago , Chicago , Illinois , USA.

PMID: 29073782
DOI: 10.1080/17460441.2018.1394839

No abstract available

Keywords: Omics; cancers; disease-on-chip; drug discovery and development; genetic disorders; systems medicine.

Publication types

Editorial

MeSH terms

Biomedical Technology / methods*
Epigenomics / methods
Genetic Therapy / methods
Genomics / methods
Humans
Pharmaceutical Preparations / administration & dosage
Pharmaceutical Research / methods*
Proteomics / methods
Systems Analysis*

Substances

Pharmaceutical Preparations